Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.
No Thumbnail Available
Date
2022
Authors
Sutera, Philip
Deek, Matthew
Guler, Ozan Cem
Hurmuz, Pervin
Reyhan, Mehmet
Rowe, Steven P.
Hrinivich, William
Ren, Lei
Kiess, Ana Ponce
Song, Daniel Y.